KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Non-Current Liabilities (2016 - 2021)

Abbott Laboratories' Other Non-Current Liabilities history spans 13 years, with the latest figure at $3.7 billion for Q4 2021.

  • For Q4 2021, Other Non-Current Liabilities changed 0.03% year-over-year to $3.7 billion; the TTM value through Dec 2021 reached $3.7 billion, changed 0.03%, while the annual FY2021 figure was $3.7 billion, 0.03% changed from the prior year.
  • Other Non-Current Liabilities for Q4 2021 was $3.7 billion at Abbott Laboratories, roughly flat from $3.7 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.9 billion in Q4 2017 and bottomed at $3.7 billion in Q4 2020.
  • The 5-year median for Other Non-Current Liabilities is $3.9 billion (2019), against an average of $4.0 billion.
  • The largest annual shift saw Other Non-Current Liabilities increased 6.73% in 2017 before it dropped 17.94% in 2018.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $4.9 billion in 2017, then decreased by 17.94% to $4.0 billion in 2018, then decreased by 1.0% to $3.9 billion in 2019, then dropped by 6.59% to $3.7 billion in 2020, then increased by 0.03% to $3.7 billion in 2021.
  • Per Business Quant, the three most recent readings for ABT's Other Non-Current Liabilities are $3.7 billion (Q4 2021), $3.7 billion (Q4 2020), and $3.9 billion (Q4 2019).